Chemiluminescence Imaging Market, By Product (Consumables, Instruments, (Automated, Semi-automated) Software & Services), By Application (Cardiology, Therapeutic Drug Monitoring, Oncology, Endocrinology, Autoimmune Disease, Infectious Disease), By End-use (Clinical Laboratories, Hospitals, Pharmaceutical & Biotechnology Companies), By Region - Global Analysis Forecast Till 2030

The Global Chemiluminescence Imaging Market was valued at USD 8.34 billion in 2021 and is expected to expand at an 8.1% CAGR from 2022 to 2030.

Chemiluminescence is the production process of light by converting chemical energy into light by a molecule that is in an excited state which is discharged as a result of a chemical reaction. It is a sensitive and low-cost method of detecting various isotopic and fluorescence techniques. Chemiluminescence imaging is the process of capturing a series of images to identify low-abundance proteins to combine the sensitive detection of chemiluminescence with the ability to locate and quantify light emission.

It also allows for the accurate determination of western blots with real-time display. It is used in various biological assays to detect quantities of biomolecules and tractracerganic ions. It can potentially become a vital tool for the rapid and accurate diagnosis of a wide range of diseases.

Market Dynamics

Drivers:

It can become a vital tool for rapidly and accurately diagnosing a wide range of diseases. Elements such as the growing demand for early and cost-effective diagnosis of chronic diseases, as well as the world's aging, are expected to influence global demand for medical imaging equipment. Some key factors driving the market growth are the introduction of technologically advanced devices and the developing healthcare sector in Asian countries.

Canon Medical Systems Corporation also launched One-Beat Spectral Cardiac CT in November 2020, with rapid kVp switching and deep learning spectral reconstruction, to acquire whole-heart spectral images in one beat. The introduction of several new products is expected to increase demand, thereby propelling market growth.

Restraints:

Frequent product recalls in imaging equipment are expected to be one of the major factors impeding global market growth during the forecast period. For example, Canon Medical System, USA, INC. recalled more than 60 Canon Aquilion Prime SP, Multislice Helical CT Scanner, TSX-303B/8L in December 2020 due to a software issue in the system.

The presence of a large and regulated refurbished equipment market has limited the adoption of new and innovative equipment in these countries, particularly in emerging and lucrative markets such as China and India. Several established and domestic players have entered this market, providing low-cost and refurbished equipment to healthcare facilities worldwide. The overall cost-benefit ratio of these refurbished devices for small and medium-sized healthcare facilities is higher, which has resulted in lower global market adoption of new systems/equipment.

Key players:

• Hoffmann-La Roche AG

• Siemens Healthineers

• Abbott Laboratories

• DiaSorin S.p.A.

• Ortho Clinical Diagnostics

• Immunodiagnostic Systems

• Beckman Coulter Inc.

• Inova Diagnostics, Inc.

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

• Macura Biotechnology Co., Ltd

• Others

Market Segmentation:

Chemiluminescence Imaging Market, By Product

• • Consumables

  • Instruments

    • Automated

    • Semi-automated

• • Software & Services

Chemiluminescence Imaging Market, By Application

• Cardiology

• Therapeutic Drug Monitoring

• Oncology

• Endocrinology

• Autoimmune Disease

• Infectious Disease

• Others

Chemiluminescence Imaging Market, By End-use

• Clinical Laboratories

• Hospitals

• Pharmaceutical & Biotechnology Companies

• Others

Chemiluminescence Imaging Market, By Regional Outlook

• North America

• Europe

• Asia Pacific

• Middle East & Africa

• Latin America

Regional Analysis:

North America had the largest market share of more than XX% in 2020 and is expected to continue to dominate the market throughout the forecast period. The presence of developed healthcare infrastructure, the widespread adoption of technologically advanced CLIA solutions, and the rising prevalence of chronic diseases are key factors driving the regional market. Furthermore, the presence of key players such as Abbott Laboratories, Beckman Coulter, Inc., DiaSorin, and Roche, as well as increased accessibility of novel CLIA systems in the United States, is expected to support regional chemiluminescence imaging market.

Asia Pacific is expected to grow with the fastest CAGR. One of the key factors of acting regional market growth is raising awareness of chronic diseases in economies such as China and India.

Furthermore, the approval of CLIA systems and the launch of novel CLIA systems by local players are expected to support the market's growth. At the China International Medical Equipment Fair in 2018, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a Chinese medical device manufacturer, debuted its new CL-6000i CLIA analyzer (CIMEF Spring 2018).

Scope of the Report:

User

Tab Content